Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humate-P individualized dosing in surgical patients with von Willebrand disease
2004-004868-69Phase 4Completed
- Sponsor
- CSL Behring
- Start
- Jan 2005
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by CSL Behring. Primary endpoints: Overall hemostatic efficacy assessment and Safety. Started Jan 2005; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on 2004-004868-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004868-69.